PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.62%
Revenue growth above 1.5x QCOM's 1.76%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
14.26%
Positive gross profit growth while QCOM is negative. John Neff would see a clear operational edge over the competitor.
51.57%
Positive EBIT growth while QCOM is negative. John Neff might see a substantial edge in operational management.
129.37%
Positive operating income growth while QCOM is negative. John Neff might view this as a competitive edge in operations.
82.32%
Positive net income growth while QCOM is negative. John Neff might see a big relative performance advantage.
84.37%
Positive EPS growth while QCOM is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
81.25%
Positive diluted EPS growth while QCOM is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.36%
Share reduction while QCOM is at 0.76%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.53%
Reduced diluted shares while QCOM is at 0.69%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
33.67%
Maintaining or increasing dividends while QCOM cut them. John Neff might see a strong edge in shareholder returns.
87.22%
OCF growth above 1.5x QCOM's 12.20%. David Dodd would confirm a clear edge in underlying cash generation.
109.06%
FCF growth above 1.5x QCOM's 8.87%. David Dodd would verify if the firm’s strategic investments yield superior returns.
104.15%
10Y revenue/share CAGR under 50% of QCOM's 438.05%. Michael Burry would suspect a lasting competitive disadvantage.
8.82%
5Y revenue/share CAGR under 50% of QCOM's 120.67%. Michael Burry would suspect a significant competitive gap or product weakness.
-4.55%
Negative 3Y CAGR while QCOM stands at 121.95%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
179.43%
10Y OCF/share CAGR at 50-75% of QCOM's 250.83%. Martin Whitman might fear a structural deficiency in operational efficiency.
55.41%
Below 50% of QCOM's 119.73%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
31.35%
3Y OCF/share CAGR under 50% of QCOM's 169.71%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
754.81%
Below 50% of QCOM's 1559.95%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
34.33%
Below 50% of QCOM's 128.75%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-6.00%
Negative 3Y CAGR while QCOM is 132.69%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
58.52%
Below 50% of QCOM's 390.93%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
32.67%
Below 50% of QCOM's 128.19%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
24.26%
Below 50% of QCOM's 75.20%. Michael Burry suspects a serious short-term disadvantage in building book value.
1208.79%
Dividend/share CAGR of 1208.79% while QCOM is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
180.15%
Dividend/share CAGR of 180.15% while QCOM is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
130.21%
3Y dividend/share CAGR above 1.5x QCOM's 49.10%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
11.85%
AR growth well above QCOM's 15.25%. Michael Burry fears inflated revenue or higher default risk in the near future.
1.18%
Inventory shrinking or stable vs. QCOM's 16.21%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
-1.54%
Negative asset growth while QCOM invests at 6.15%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
1.43%
Under 50% of QCOM's 5.63%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-9.11%
We’re deleveraging while QCOM stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-7.16%
Our R&D shrinks while QCOM invests at 9.76%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
2.61%
SG&A declining or stable vs. QCOM's 12.61%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.